Eli Lilly supports Alto Neuroscience in $45m Series C round

Eli Lilly supports Alto Neuroscience in $45m Series C round

Submitted by admin on November 22, 2023 - 11:30am
Source: 
Clinical Trials Arena
News Tags: 
Eli Lilly
Alto Neuroscience
funding
psychiatric diesase
Headline: 
Eli Lilly supports Alto Neuroscience in $45m Series C round
snippet: 

The funding will go towards the development of Alto Neuroscience's four CNS candidates, with Phase II study data readouts expected by early 2025.

Do Not Allow Advertisers to Use My Personal information